文献速递肾小球疾病慢性肾脏病遗传性与小管间质肾病

儿童肾病综合征的长期结局

Long-term outcomes of childhood nephrotic syndrome.
PubMed 文献 · Kidney Int · 2026-09-26

本文综述儿童起发性特发性肾病综合征的长期结局。初始激素反应是区分激素敏感型与激素抵抗型的最强预后因素,约三分之一初始激素抵抗型患儿存在单基因病因。激素敏感型多呈复发缓解病程,约四分之一成年后仍有复发;激素抵抗型并发症及肾衰竭风险更高。

要点

  • 初始激素反应是儿童特发性肾病综合征最强的预后因素。
  • 约三分之一初始激素抵抗型患儿存在单基因病因。
  • 激素敏感型约四分之一成年后仍至少复发一次。

核心结论

  • 儿童起发性特发性肾病综合征的长期结局因临床表型、遗传诊断和治疗反应而异,需据此进行风险分层并关注向成人医疗过渡。
  • 激素敏感型总体预后较好,肾衰竭和死亡不常见;激素抵抗型并发症和肾衰竭风险更高。

研究设计与样本

  • 综述,汇总儿童起发性特发性肾病综合征长期结局的现有证据。

主要发现

  • 激素敏感型通常呈复发缓解病程,一半患者为频繁复发或激素依赖型。
  • 激素敏感型中约四分之一成年后至少复发一次,持续复发预测因素包括儿童期频繁复发或激素依赖及需二线免疫抑制。
  • 激素敏感型中不足10%可演变为继发性激素抵抗。
  • 激素抵抗型并发症风险更高,包括生长受损、肥胖、高血压和心血管风险、骨质疏松、白内障、钙调神经磷酸酶抑制剂肾毒性、急性肾损伤和进展性慢性肾脏病。
  • 单基因和/或多药耐药激素抵抗型患者肾衰竭风险高3至4倍。

关键数值与推荐

  • 约三分之一初始激素抵抗型患儿存在单基因病因。
  • 激素敏感型中一半患者为频繁复发或激素依赖型,约四分之一成年后至少复发一次,不足10%演变为继发性激素抵抗。
  • 单基因和/或多药耐药激素抵抗型患者肾衰竭风险高3至4倍。

临床怎么用

  • 依据初始激素反应区分激素敏感型与激素抵抗型,并进行长期风险分层随访。
  • 对激素抵抗型考虑遗传诊断,关注治疗和疾病相关并发症及向成人医疗过渡。

局限性

  • 原文未报告具体研究类型、检索范围、样本量及随访时限等细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Idiopathic nephrotic syndrome is the most common chronic glomerular disease in children. Corticosteroids remain the first-line therapy, and the initial response, differentiating steroid-sensitive nephrotic syndrome from steroid-resistant nephrotic syndrome forms, is the strongest prognostic factor. Although most childhood-onset idiopathic nephrotic syndrome results from an incompletely defined dysregulation of the immune system, up to one-third of children with initial steroid-resistant nephrotic syndrome have a monogenic etiology. Steroid-sensitive nephrotic syndrome typically follows a relapsing-remitting course, with one-half of the patients having frequent relapses or steroid-dependent nephrotic syndrome. Although earlier studies suggested that most patients with steroid-sensitive nephrotic syndrome achieve sustained remission by puberty, approximately one-fourth experience at least 1 relapse in adulthood. Key predictors of persistent relapsing disease include frequently relapsing or steroid-dependent nephrotic syndrome in childhood and the need for second-line immunosuppression. The disease may evolve into secondary steroid resistance in <10% of patients with steroid-sensitive nephrotic syndrome. Kidney failure and death remain uncommon. In contrast, steroid-resistant nephrotic syndrome is associated with higher risks of therapy- and disease-related complications, including growth impairment, obesity, hypertension and cardiovascular risk, osteoporosis, cataracts, calcineurin inhibitor-induced nephrotoxicity, acute kidney injury, and progressive chronic kidney disease. The risk of kidney failure is 3- to 4-fold higher in patients with monogenic and/or multidrug-resistant steroid-resistant nephrotic syndrome. This review synthesizes current evidence on the long-term outcomes of childhood-onset idiopathic nephrotic syndrome, and highlights risk stratification across clinical phenotypes, genetic diagnosis and treatment response, and challenges during transition to adult care.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Boyer O, Sinha A, Oliva-Dámaso N, et al. Long-term outcomes of childhood nephrotic syndrome. Kidney Int. 2026. PMID: 42800615. doi:10.1016/j.kint.2026.06.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。